Page 125 - Academic Press Encyclopedia of Physical Science and Technology 3rd BioTechnology
P. 125

P1: GLQ/GUB  P2: FYK Final Pages
 Encyclopedia of Physical Science and Technology  EN007K-319  July 2, 2001  17:53







              Hybridomas, Genetic Engineering of                                                          435

              C.  Affinity Binding                               TABLE II  Human or Human Hybrid Fusion Partners
              Certain bacterial cell wall proteins (called Protein A and                         Immunoglobulin
                                                                     Cell type        Cell line    expression
              Protein  G)  bind  with  high  affinity  to  mammalian  im-
              munoglobulins. Protein A is derived from Staphylococcus  Human myeloma  SK007      Yes
              aureus and has a strong affinity for antibodies. This al-  Human lymphoblastoid  RH-L4  Yes but nonsecretor
              lows antibodies to be isolated by chromatography columns  Human lymphoblastoid  GM1500  Yes
              which contain inert beads conjugated to Protein A or G.  Human lymphoblastoid  KR4  Yes
              If a sample (such as Mab-containing culture medium) is  Human lymphoblastoid  LICR-LON  Yes
              run through the column at neutral pH only antibodies will
                                                                Human/human hybridoma  KR12      Yes
              bind, allowing all other components to be washed out.
                                                                Human/mouse hybridoma  SHM-D33   Yes but nonsecretor
              Pure antibody can then be eluted from the column by a
              low pH buffer.
                Suitable  affinity  columns  of  this  type  have  been  de-  with humans and the source of human lymphocytes is lim-
              signed for use with HPLC and this offers an extremely  ited to samples of peripheral blood. These can be taken
              rapid method of analyzing or purifying antibodies. How-  from patients who have acquired an immunity against a
              ever, the method will detect any mammalian immunoglob-  particular compound or disease. Alternatively, methods of
              ulin  which  means  that  the  immunoglobulin  content  of  in vitro immunization of human lymphocytes are possible.
              the serum used in the growth medium may interfere with  This approach requires the optimization of conditions for
              analysis.                                         human B-lymphocyte activation by use of the appropriate
                HPLC  affinity  columns  (such  as  ProAnaMabs  from  cytokines and growth factors.
              Hyclone) offer a rapid assay for measuring antibodies in
              serum-free culture medium and they could be used instead
                                                                B.  Immortalization and Chromosome
              of ELISA. Affinity chromatography can also be used for
                                                                   Instability
              large-scale antibody extraction, although the preparative
              Protein A or G columns are expensive.             There must be a suitable human fusion partner to immor-
                                                                talize the B-lymphocytes. Human myeloma cell lines are
                                                                difficult to grow in culture. Human lymphoblastoid cell
              XIII.  HUMAN MONOCLONAL ANTIBODIES                lines have been used as fusion partners but the frequency
                                                                of cell fusion and genetic stability of the resulting hybrido-
              Although  murine-derived  monoclonal  antibodies  are  mas is low compared with equivalent fusions with mouse
              widely used as laboratory reagents, in affinity purifica-  cells. An alternative approach is to immortalize the acti-
              tion and clinical diagnostic tests, they have had limited  vated human lymphocytes by transfection with oncogenic
              success in human therapy. Immunoglobulins synthesized  DNA or by transformation by a virus.
              from  mice  and  humans  have  different  constant  regions
              and so any antibody of mouse origin injected into a hu-
                                                                C. Antibody Secretion of Human
              man could elicit an undesirable immune reactions. First,
              although the antigen-binding site might be appropriate for  Parental Fusion Partners
              the target the antibody will not produce appropriate hu-  Mouse myelomas commonly used in fusion are nonan-
              man effector responses such as those of complement and  tibody secretors. The value of this is that the resulting
              Fc receptor binding. Second, the human immune system  hybridomas only secrete the antibody associated with the
              will produce antibodies against the murine immunoglob-  fused B-lymphocyte. Therefore, the culture product will
              ulin. This is referred to as the human anti-murine antibody  be a single selected antibody type. However, most of the
              immune response (HAMA).                           human myeloma or lymphoblastoid cells commonly used
                This presents an obstacle in developing therapeutic an-  for hybridization are immunoglobulin secretors (Table II).
              tibodies from a murine source. However, there are at least  This means that the resulting selected human hybridoma
              three major difficulties in producing human hybridoma  will secrete at least two antibodies, which are those asso-
              cells capable of secreting human monoclonal antibodies.  ciated with each of the parental cells.

              A.  The Source of Antibody-Secreting              XIV. RECOMBINANT ANTIBODIES
                 Lymphocytes
              In generating murine hybridomas, the spleen of an immu-  A further possibility is the humanization of monoclonal
              nized mouse is used as a source of the mixed lymphocyte  antibodies originally produced from mice. This pro-
              population for cell selection. Clearly this is not possible  cess involves antibody engineering which relies on the
   120   121   122   123   124   125   126   127   128   129   130